Loading…

Eli Lilly announced plans to construct a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany, for injectable products. The site is expected to be operational beginning in 2027 and will employ up to 1,000 workers.
“Every investment into our manufacturing capacity around the world is a renewed commitment to patients today – and to those who may need our medicines tomorrow.”nasdaq.com
Summarized from public sources; check the original articles before acting on it.